by Waylon Wright | Aug 28, 2018
Pearl Pathways announces the hiring of Cara Frosch, MBA, PA as Director of Business Development. Frosch brings over 35 years of diversified biopharmaceutical and medical device experience in human and animal health to Pearl Pathways. After a short stint in clinical...
by Waylon Wright | Aug 27, 2018
A new draft guidance issued by the U.S. Food and Drug Administration (FDA) provides advice to sponsors regarding the design and conduct of first-in-human (FIH) clinical trials for cancer drugs and biologics. The draft guidance, issued in August 2018, describes the use...
by Waylon Wright | Jun 19, 2018
The Cancer Prevention and Research Institute of Texas (CPRIT) announces a new award targeting early-state oncology startups. The new grant mechanism, known as the Seed Award, allows companies to apply for up to $3 million in nondilutive funding to support development...
by Waylon Wright | May 17, 2018
Patti Connolly, Director of Clinical Services at Pearl Pathways, is a featured speaker at MAGI’s Clinical Research Conference – 2018 East. MAGI is an organization that aims to streamline clinical research by standardizing best practices for clinical...
by Waylon Wright | May 16, 2018
Robert Seevers, Senior Advisor at Pearl Pathways, will travel to Washington, DC May 17-18, 2018 to speak about Good Distribution Practices (GDP). Seevers will speak to the Consumer Healthcare Products Association (CHPA) on behalf of the United States Pharmacopeia...